Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-06-12Clinical Trial Update: Extension Study Investigating the Long-Term Safety and Tolerability of Repeat Doses of FE200486 in Prostate Cancer Patients [Phase 2]
An extension Phase 2 study evaluating long-term safety and tolerability of repeat doses of FE200486 in prostate cancer patients was terminat…
-
CLINICAL_TRIALS trial_result · 2009-06-11Clinical Trial Update: Study Investigating the Long-Term Safety and Tolerability of Repeated Doses of Degarelix in Prostate Cancer Patients [Phase 2]
Phase 2 study evaluating long-term safety and tolerability of repeated degarelix doses in prostate cancer; the trial was terminated but resu…
-
CLINICAL_TRIALS trial_result · 2009-06-05Clinical Trial Update: Study Investigating the Pharmacokinetics, Pharmacodynamics and Safety of FE200486 [Phase 2]
A Phase 2 study evaluating the pharmacokinetics, pharmacodynamics and safety of FE200486 in prostate cancer has completed and posted results…
-
CLINICAL_TRIALS trial_result · 2009-06-05Clinical Trial Update: Molecular Urine Tests for Prostate Cancer
A completed UC Irvine-sponsored clinical trial evaluated molecular urine tests for detecting prostate cancer, with this document providing a…
-
CLINICAL_TRIALS trial_result · 2009-05-27Clinical Trial Update: Casodex vs Placebo in Non-Metastatic Early Prostate Cancer [Phase 3]
A Phase 3 trial comparing Casodex to placebo in non-metastatic early prostate cancer has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-05-08Clinical Trial Update: Efficacy and Safety Study of the Therapeutic Vaccine PEP223 in Prostate Cancer Patients [Phase 1, Phase 2]
Update on an early-stage trial evaluating the efficacy and safety of the therapeutic vaccine PEP223 in prostate cancer (Phase 1/2).
-
CLINICAL_TRIALS trial_result · 2009-04-23Clinical Trial Update: Gefitinib in the Treatment of the First Relapse of Prostate Cancer Beyond Prostatectomy or Radiotherapy [Phase 2]
Phase 2 clinical trial evaluating Gefitinib (Iressa) for first relapse prostate cancer after prostatectomy or radiotherapy has completed. Th…
-
CLINICAL_TRIALS trial_result · 2009-04-23Clinical Trial Update: Safety Study to Explore Combination of Gefitinib (ZD1839, Iressa) and Radiotherapy in Non-Metastatic Prostate Cancer [Phase 1, Phase 2]
This trial update reports the completion of a Phase 1/Phase 2 safety study evaluating the combination of gefitinib with radiotherapy in non-…
-
CLINICAL_TRIALS trial_result · 2009-04-23Clinical Trial Update: Open Label Trial to Assess Iressa in Prostate Cancer Patients [Phase 2]
Open-label Phase 2 trial evaluating the EGFR inhibitor Iressa (gefitinib) in patients with prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2009-04-16Clinical Trial Update: The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate Cancer [Phase 3]
Phase 3 results evaluate one-month degarelix dosing regimens in prostate cancer, focusing on efficacy and safety. The trial was sponsored by…
-
CLINICAL_TRIALS trial_result · 2009-04-03Clinical Trial Update: Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer [Phase 1]
Phase 1 study evaluating motexafin gadolinium in combination with docetaxel for advanced cancers; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2009-03-31Clinical Trial Update: 131-I-TM-601 Study in Adults With Solid Tumors [Phase 1]
Phase 1 update on the radiopharmaceutical 131I-TM-601 in adults with solid tumors, including breast cancer, non-small cell lung cancer, mela…
-
CLINICAL_TRIALS trial_result · 2009-03-31Clinical Trial Update: Dose Finding Trial With a New Treatment (Degarelix) for Prostate Cancer [Phase 2]
Phase 2 dose-finding trial of the new treatment degarelix for prostate cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2009-03-31Clinical Trial Update: The Efficacy and Safety of FE 200486 in Treatment of Patients Suffering From Prostate Cancer [Phase 2]
A Phase 2 clinical trial update evaluating FE 200486 for efficacy and safety in prostate cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2009-03-31Clinical Trial Update: Investigation of a New Trial Drug (FE200486) in Prostate Cancer Patients [Phase 2]
Phase 2 clinical trial update for FE200486 in prostate cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2009-03-27Clinical Trial Update: Neoadjuvant Therapy With Docetaxel and Ketoconazole in Patients With High-Risk Prostate Cancer: A Pilot Study [NA]
A pilot study explored neoadjuvant therapy with docetaxel and ketoconazole in high-risk prostate cancer; the trial's current status is unkno…
-
CLINICAL_TRIALS trial_result · 2009-03-20Clinical Trial Update: A Parallel Group Comparison of the Efficacy and Safety of Degarelix at Two Different Dosing Regimens in Patients With Prostate Cancer [Phase 2]
This Phase 2 parallel-group trial evaluated two dosing regimens of degarelix in patients with prostate cancer, reporting efficacy and safety…
-
CLINICAL_TRIALS trial_result · 2009-03-20Clinical Trial Update: Extension Study Investigating the Long-Term Safety and Tolerability of Repeat Doses of FE200486 in Prostate Cancer Patients [Phase 2]
Phase 2 extension study terminated; assessed long-term safety and tolerability of repeat doses of FE200486 in prostate cancer patients, with…
-
CLINICAL_TRIALS trial_result · 2009-03-12Clinical Trial Update: Effects of Soy Compounds on Breast Cancer, Prostate Cancer, and Bone Health [Phase 2]
Phase 2 clinical trial evaluating the effects of soy compounds on breast cancer, prostate cancer, and bone health. The study status is compl…
-
CLINICAL_TRIALS trial_result · 2009-02-26Clinical Trial Update: Study of Sorafenib and Docetaxel in Metastatic Prostate Cancer [Phase 2]
A Phase 2 trial evaluating the combination of sorafenib and docetaxel in metastatic prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2009-02-20Clinical Trial Update: Multi-Center Phase II Study to Compare MER-101 20mg Tablets to Intravenous Zometa 4mg in Male Bisphosphonate-Naive, Hormone Refractory Prostate Cancer Patients [Phase 2]
A completed Phase II multi-center trial comparing MER-101 20 mg tablets to intravenous zoledronic acid (Zometa) 4 mg in bisphosphonate-naive…
-
CLINICAL_TRIALS trial_result · 2009-02-11Clinical Trial Update: Abarelix Versus Goserelin Plus Bicalutamide in Patients With Advanced or Metastatic Prostate Cancer [Phase 3]
This Phase 3 trial comparing abarelix to goserelin plus bicalutamide in advanced or metastatic prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2009-01-30Clinical Trial Update: Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer [Phase 2]
Phase 2 study of AS1404 with docetaxel in hormone-refractory metastatic prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2009-01-21Clinical Trial Update: Calcifidol Therapy in Men With Cancer [Phase 2]
A Phase 2 trial evaluating calcifidol therapy in men with cancer (prostate cancer) has completed.
-
CLINICAL_TRIALS trial_result · 2009-01-21Clinical Trial Update: Study of Prostate Cancer in Black and White U.S. Veterans
A completed clinical trial studying prostate cancer in Black and White U.S. veterans.